Lymphangioleiomyomatosis - The pathophysiology of diminished exercise capacity

被引:38
作者
Crausman, RS
Jennings, CA
Irvin, CG
King, TE
机构
[1] NATL JEWISH CTR IMMUNOL & RESP MED,ILD SCOR PROGRAM,DEPT MED,DENVER,CO 80206
[2] UNIV COLORADO,HLTH SCI CTR,DEPT MED,DIV PULM SCI & CRIT CARE MED,DENVER,CO 80262
关键词
D O I
10.1164/ajrccm.153.4.8616568
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Dyspnea with exertion is nearly always present in patients with pulmonary lymphangioleiomyomatosis, but the mechanisms underlying exercise impairment have not been well defined. Spirometry, lung volumes, lung mechanics, and exercise physiology were performed on a cohort of 16 patients. We determined the relative contribution of airflow limitation, gas exchange abnormalities, and pulmonary vascular abnormalities to the exercise performance achieved. The patients had normal TLC and Vtg, but RV was elevated in 88% of the subjects. A moderate to severe obstructive pattern was present in 69% of the subjects, and the DL(CO) was reduced, often markedly, in 81% of the subjects. Exercise performance was limited (work load, 68% +/- 6) with abnormalities of ventilatory function and gas exchange present. Strong correlations between overall exercise performance (percent predicted Vo(2)max and maximal work load achieved) and indices of airflow and vascular involvement were present. Poor exercise performance was due primarily to ventilatory limitation. The etiology of this ventilatory limitation appears twofold. First, subjects had a reduced ventilatory ceiling because of airflow limitation. Second, subjects demonstrated an excessive ventilatory response as a result of increased dead-space ventilation thought to be due to disease-associated cystic changes and associated pulmonary vascular dysfunction or destruction.
引用
收藏
页码:1368 / 1376
页数:9
相关论文
共 35 条
[11]  
DINAKARA P, 1970, AM REV RESPIR DIS, V102, P965
[12]   ROLE OF ELASTIC FIBER DEGRADATION IN EMPHYSEMA-LIKE LESIONS OF PULMONARY LYMPHANGIOMYOMATOSIS [J].
FUKUDA, Y ;
KAWAMOTO, M ;
YAMAMOTO, A ;
ISHIZAKI, M ;
BASSET, F ;
MASUGI, Y .
HUMAN PATHOLOGY, 1990, 21 (12) :1252-1261
[13]  
GOLDMAN HI, 1959, AM REV TUBERC PULM, V79, P457
[14]  
Jones NL., 1982, Clinical exercise testing, V2nd edn
[15]  
JOZWIAK S, 1990, AM J ROENTGENOL, V155, P419
[16]   RENAL ANGIOMYOLIPOMA IN ASSOCIATION WITH PULMONARY LYMPHANGIOLEIOMYOMATOSIS - FORME-FRUSTE OF TUBEROUS SCLEROSIS [J].
KERR, LA ;
BLUTE, ML ;
RYU, JH ;
SWENSEN, SJ ;
MALEK, RS .
UROLOGY, 1993, 41 (05) :440-444
[17]   PULMONARY LYMPHANGIOLEIOMYOMATOSIS - A REPORT OF 46 PATIENTS INCLUDING A CLINICOPATHOLOGICAL STUDY OF PROGNOSTIC FACTORS [J].
KITAICHI, M ;
NISHIMURA, K ;
ITOH, H ;
IZUMI, T .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 151 (02) :527-533
[18]   PULMONARY AND EXTRAPULMONARY LYMPHANGIOLEIOMYOMATOSIS - REPORT OF A CASE WITH BILATERAL RENAL ANGIOMYOLIPOMAS, MULTIFOCAL LYMPHANGIOLEIOMYOMATOSIS, AND A GLIAL POLYP OF THE ENDOCERVIX [J].
LACK, EE ;
DOLAN, MF ;
FINISIO, J ;
GROVER, G ;
SINGH, M ;
TRICHE, TJ .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1986, 10 (09) :650-657
[19]  
MOHSENIFAR Z, 1981, AM REV RESPIR DIS, V123, P508
[20]  
Morris A, 1984, Clinical Pulmonary Function Testing: A Manual of Uniform Laboratory Procedures, V2nd